![](http://keyrx.com/cdn/shop/files/unnamed.png?v=1696965836&width=1500)
Chief Executive Officer
Robert W. Sims, MBA
Military veteran with 20 years of progressive industry experience involving design, development, and launch of device, diagnostic and therapeutic products across multiple specialties.
![](http://keyrx.com/cdn/shop/files/1614033799200.png?v=1696965836&width=1500)
Chief Legal Officer
Manya Deehr, JD
25 years of collaborative experience facilitating debt Financing and IPO activity for drug discover, development and commercialization deals in excess of $25B.
![](http://keyrx.com/cdn/shop/files/DSC_0737.png?v=1696965836&width=1500)
Chief Science Officer
Shanta Bantia, PhD
20+ years in R&D, grant procurement, and clinical trial operations; Dr. Bantia has raised an excess of $200M via grants, holds multiple U.S. patents, and has advanced several compounds to market.
![](http://keyrx.com/cdn/shop/files/Photo_25_2x_16640383-a745-442a-b386-e7132a3cbedc.png?v=1696965836&width=1500)
Chief Medical Officer
Scott Sweazy, MD
A regarded thought leader with 30+ years of medical practice who has served as a pioneering advisor for first-to-market offerings that enhance patient experiences and improve medical outcomes.